Cargando…
Oral paracetamol versus oral ibuprofen for closure of haemodynamically significant patent ductus arteriosus in preterm neonates (<32 weeks): a blinded, randomised, active-controlled, non-inferiority trial
INTRODUCTION: Haemodynamically significant patent ductus arteriosus (hsPDA) is a common cause of mortality and morbidity in preterm infants. Existing medical therapies with ibuprofen or indomethacin have multiple adverse effects. Hence, an alternative drug like paracetamol given through oral route w...
Autores principales: | Kumar, Ashutosh, Sundaram, Venkataseshan, Yadav, Rahul, Oleti, Tejo Pratap, Murki, Srinivas, Krishna, Arun, Sundaram, Mangalabharathi, Saini, Shiv Sajan, Dutta, Sourabh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862198/ https://www.ncbi.nlm.nih.gov/pubmed/29637155 http://dx.doi.org/10.1136/bmjpo-2017-000143 |
Ejemplares similares
-
Oral paracetamol versus oral ibuprofen for treatment of patent ductus arteriosus
por: Al-lawama, Manar, et al.
Publicado: (2017) -
Oral ibuprofen is superior to oral paracetamol for patent ductus arteriosus in very low and extremely low birth weight infants
por: Lu, Jinmiao, et al.
Publicado: (2019) -
Comparison of Oral Paracetamol versus Ibuprofen in Premature Infants with Patent Ductus Arteriosus: A Randomized Controlled Trial
por: Dang, Dan, et al.
Publicado: (2013) -
Oral paracetamol vs. oral ibuprofen in the treatment of symptomatic patent ductus arteriosus in premature infants: A randomized controlled trial
por: Yang, Bo, et al.
Publicado: (2016) -
Comparison of Oral Acetaminophen Versus Ibuprofen in Premature Infants With Patent Ductus Arteriosus
por: Bagheri, Mohammad Mehdi, et al.
Publicado: (2016)